
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Japanese Azuki Bean (Vigna angularis) contains flavonoids and saponins that inhibit α-glucosidase by 91.5% and pancreatic lipase by 40%, demonstrating significant antidiabetic and anti-obesity effects. Its polysaccharides activate the insulin-PI3K-AKT pathway, upregulating glucose transport genes including Insr, Irs-1, and Glut-2.

Reported Benefits (Provisional)
Origin & History

The Japanese Azuki Bean (Vigna angularis) is a small, reddish-brown legume native to East Asia, particularly Japan, thriving in temperate climates with well-drained, fertile soils. It is a cornerstone of traditional diets, valued for its dense nutritional profile and functional benefits in supporting metabolic and cardiovascular health.
Research Narrative (Provisional)
Scientific studies document the blood sugar-regulating, antioxidant, and cardiovascular benefits of Vigna angularis. Research highlights its role in enhancing digestion, supporting heart health, and regulating blood sugar levels, particularly within traditional dietary patterns.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Dietary Fiber: Supports digestion, promotes satiety, and enhances bowel regularity. - Plant Protein: Supports muscle growth, repair, and overall bodily function. - Iron: Essential for oxygen transport and energy production. - Folate: Supports cellular regeneration and metabolic health. - Anthocyanins: Potent antioxidants that reduce oxidative damage and support heart health.
Reported Mechanism (Provisional)
Azuki bean flavonoids and saponins inhibit α-glucosidase (91.5% inhibition at 1 mg/mL) and pancreatic lipase (~40% inhibition), reducing carbohydrate breakdown and fat absorption. Polysaccharides activate the insulin-PI3K-AKT signaling pathway, upregulating mRNA expression of Insr, Irs-1, Pi3k, Akt, and Glut-2 genes in diabetic tissue. Polyphenols including proanthocyanidins, catechins, and chlorogenic acid provide additional glucose-lowering effects through α-glucosidase inhibition.
Clinical Narrative (Provisional)
Human clinical evidence is extremely limited, with only one small trial showing azuki bean juice (200 mL daily for 12 weeks) reduced serum triglycerides, though specific reduction values were not quantified. Most evidence derives from animal studies demonstrating blood glucose reduction in type 2 diabetic mice and in vitro enzyme inhibition assays. The pancreatic lipase inhibition was measured at 51.7% activity remaining at 50 µL and 32.6% at 100 µL azuki juice in laboratory conditions. Clinical efficacy in humans requires substantial additional research to establish therapeutic dosing and outcomes.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







